WE ARE CANNASOUL ANALYTICS
CannaSoul Analytics is a global leader in cannabis research and development. Dedicated to developing scientific intellectual property, medical product and technologies. CannaSoul is backed by our robust scientific analysis.
Founded by world-renowned cannabis researcher Prof. Dedi Meiri from the Technion – Israel Institute of Technology, CannaSoul utilizes proprietary analytical expertise based on our accumulated clinical data and Prof. Meiri’s pioneering research. Adhering to the principles and spirit of GCLP, the company is accredited under ISO 17025 and operates under the supervision of the Israel Health Ministry’s Cannabis Unit.
Well-developed analytic capabilities for Phytocannabinoids and their metabolites along with Endocannabinoids in serum, plasma, and biological tissues (PK studies)
Comprehensive analysis of the Endocannabinoid System, including availability of Endocannabinoids, prostaglandins, and cannabinoid receptors
PROOF OF CONCEPT
The CannaSoul product development spectrum is centered on specific indications, using formulations that incorporate only minimal essential compounds
CannaSoul has a unique ability to map a wide variety of active compounds both in plant and biological samples. We analyze a significant percentage out of all the active compounds known in the literature.